ALDX
Price
$5.22
Change
-$0.03 (-0.57%)
Updated
Oct 9, 01:41 PM (EDT)
29 days until earnings call
ORMP
Price
$2.40
Change
+$0.06 (+2.58%)
Updated
Oct 9, 01:59 PM (EDT)
30 days until earnings call
Ad is loading...

ALDX vs ORMP

Header iconALDX vs ORMP Comparison
Open Charts ALDX vs ORMPBanner chart's image
Aldeyra Therapeutics
Price$5.22
Change-$0.03 (-0.57%)
Volume$3.3K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.40
Change+$0.06 (+2.58%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ALDX vs ORMP Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALDX vs. ORMP commentary
Oct 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a StrongSell and ORMP is a Buy.

COMPARISON
Comparison
Oct 09, 2024
Stock price -- (ALDX: $5.25 vs. ORMP: $2.32)
Brand notoriety: ALDX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 59% vs. ORMP: 62%
Market capitalization -- ALDX: $320.28M vs. ORMP: $99.48M
ALDX [@Biotechnology] is valued at $320.28M. ORMP’s [@Biotechnology] market capitalization is $99.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 3 bullish, 5 bearish.
  • ORMP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -0.76% price change this week, while ORMP (@Biotechnology) price change was -3.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

ORMP is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($320M) has a higher market cap than ORMP($99.5M). ALDX YTD gains are higher at: 49.573 vs. ORMP (0.433). ORMP has higher annual earnings (EBITDA): 25.5M vs. ALDX (-35.59M). ORMP has more cash in the bank: 153M vs. ALDX (120M). ORMP has less debt than ALDX: ORMP (486K) vs ALDX (15.6M). ALDX (0) and ORMP (0) have equivalent revenues.
ALDXORMPALDX / ORMP
Capitalization320M99.5M322%
EBITDA-35.59M25.5M-140%
Gain YTD49.5730.43311,451%
P/E RatioN/A4.78-
Revenue00-
Total Cash120M153M78%
Total Debt15.6M486K3,210%
FUNDAMENTALS RATINGS
ALDX vs ORMP: Fundamental Ratings
ALDX
ORMP
OUTLOOK RATING
1..100
587
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9654
PRICE GROWTH RATING
1..100
4659
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (43) in the Biotechnology industry is in the same range as ORMP (54) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALDX (96) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than ALDX’s over the last 12 months.

ALDX's Price Growth Rating (46) in the Biotechnology industry is in the same range as ORMP (59) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as ALDX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXORMP
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL225.774.08
+1.84%
Apple
TSLA244.503.67
+1.52%
Tesla
SPY573.175.37
+0.95%
SPDR® S&P 500® ETF Trust
BTC.X62131.970000-104.691410
-0.17%
Bitcoin cryptocurrency
GME20.71-0.19
-0.91%
GameStop Corp

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with OMER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-0.57%
OMER - ALDX
48%
Loosely correlated
+1.04%
CANF - ALDX
46%
Loosely correlated
+2.00%
ORMP - ALDX
45%
Loosely correlated
-3.73%
OLMA - ALDX
39%
Loosely correlated
+0.62%
MTNB - ALDX
36%
Loosely correlated
+1.86%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-3.73%
KRYS - ORMP
48%
Loosely correlated
-0.15%
ALDX - ORMP
45%
Loosely correlated
-0.57%
BPMC - ORMP
44%
Loosely correlated
-2.04%
BTAI - ORMP
44%
Loosely correlated
+0.95%
INO - ORMP
44%
Loosely correlated
+6.75%
More